ILLICIT GAMMA-HYDROXYBUTYRATE (GHB) AND PHARMACEUTICAL SODIUM OXYBATE (XYREM): DIFFERENCES IN CHARACTERISTICS AND MISUSE
Gardado en:
CARTER, L.P., ET AL., ILLICIT GAMMA-HYDROXYBUTYRATE (GHB) AND PHARMACEUTICAL SODIUM OXYBATE (XYREM): DIFFERENCES IN CHARACTERISTICS AND MISUSE. DRUG AND ALCOHOL DEPENDENCE, Vol. 104, no. 1-2 (2009), p. 1-10.
Ref.
165887
Localización:
SIIS R.854 Archivo
Palabras clave:
Abusos sexuales, Delincuencia, Drogas de síntesis, Drogodependencias, Efectos, Fármacos, EE.UU.
Abusos sexuales, Delincuencia, Drogas de síntesis, Drogodependencias, Efectos, Fármacos, EE.UU.
Títulos similares: ILLICIT GAMMA-HYDROXYBUTYRATE (GHB) AND PHARMACEUTICAL SODIUM OXYBATE (XYREM): DIFFERENCES IN CHARACTERISTICS AND MISUSE
- USE OF SODIUM GAMMA-HYDROXYBUTYRATE (GHB) IN ALCOHOLIC HEROIN ADDICTS AND POLYDRUG-ABUSERS
- EFFECTS OF GAMMA-HYDROXYBUTYRIC ACID (GHB) IN OPIOID-DEPENDENT PATIENTS
- USE, FUNCTION, AND SUBJECTIVE EXPERIENCES OF GAMMA-HYDROXYBUTYRATE (GHB)
- COMPARISON OF THE BEHAVIORAL EFFECTS OF GAMMA-HYDROXYBUTYRIC ACID (GHB) AND ITS 4-METHYL-SUBSTITUDED ANALOG, GAMMA-HYDROXYVALERIC ACID (GHV)
- SYSTEMATIC ASSESSMENT OF GAMMA HYDROXYBUTYRATE (GHB) EFFECTS DURING AND AFTER ACUTE INTOXICATION
- CLINICAL FEATURES AND MANAGEMENT OF GAMMA-HYDROXYBUTYRATE (GHB) WITHDRAWAL: A REVIEW